Global In-vitro Toxicity Testing Market Size, Status and Forecast 2019-2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global In-vitro Toxicity Testing Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Static Well Plate System
- 1.4.3 Multi-compartmental Perfused Systems
- 1.5 Market by Application
- 1.5.1 Global In-vitro Toxicity Testing Market Share by Application (2019-2025)
- 1.5.2 Pharmaceutical and Biotechnology Companies
- 1.5.3 Academic and Research Institutions
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 In-vitro Toxicity Testing Market Size
- 2.2 In-vitro Toxicity Testing Growth Trends by Regions
- 2.2.1 In-vitro Toxicity Testing Market Size by Regions (2019-2025)
- 2.2.2 In-vitro Toxicity Testing Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
- 3.1 In-vitro Toxicity Testing Market Size by by Players
- 3.1.1 Global In-vitro Toxicity Testing Revenue by by Players (2014-2019)
- 3.1.2 Global In-vitro Toxicity Testing Revenue Market Share by by Players (2014-2019)
- 3.1.3 Global In-vitro Toxicity Testing Market Concentration Ratio (CR5 and HHI)
- 3.2 In-vitro Toxicity Testing Key Players Head office and Area Served
- 3.3 Key Players In-vitro Toxicity Testing Product/Solution/Service
- 3.4 Date of Enter into In-vitro Toxicity Testing Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global In-vitro Toxicity Testing Market Size by Type (2014-2019)
- 4.2 Global In-vitro Toxicity Testing Market Size by Application (2014-2019)
5 North America
- 5.1 North America In-vitro Toxicity Testing Market Size (2014-2019)
- 5.2 In-vitro Toxicity Testing Key Players in North America
- 5.3 North America In-vitro Toxicity Testing Market Size by Type
- 5.4 North America In-vitro Toxicity Testing Market Size by Application
6 Europe
- 6.1 Europe In-vitro Toxicity Testing Market Size (2014-2019)
- 6.2 In-vitro Toxicity Testing Key Players in Europe
- 6.3 Europe In-vitro Toxicity Testing Market Size by Type
- 6.4 Europe In-vitro Toxicity Testing Market Size by Application
7 China
- 7.1 China In-vitro Toxicity Testing Market Size (2014-2019)
- 7.2 In-vitro Toxicity Testing Key Players in China
- 7.3 China In-vitro Toxicity Testing Market Size by Type
- 7.4 China In-vitro Toxicity Testing Market Size by Application
8 Japan
- 8.1 Japan In-vitro Toxicity Testing Market Size (2014-2019)
- 8.2 In-vitro Toxicity Testing Key Players in Japan
- 8.3 Japan In-vitro Toxicity Testing Market Size by Type
- 8.4 Japan In-vitro Toxicity Testing Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia In-vitro Toxicity Testing Market Size (2014-2019)
- 9.2 In-vitro Toxicity Testing Key Players in Southeast Asia
- 9.3 Southeast Asia In-vitro Toxicity Testing Market Size by Type
- 9.4 Southeast Asia In-vitro Toxicity Testing Market Size by Application
10 India
- 10.1 India In-vitro Toxicity Testing Market Size (2014-2019)
- 10.2 In-vitro Toxicity Testing Key Players in India
- 10.3 India In-vitro Toxicity Testing Market Size by Type
- 10.4 India In-vitro Toxicity Testing Market Size by Application
11 Central & South America
- 11.1 Central & South America In-vitro Toxicity Testing Market Size (2014-2019)
- 11.2 In-vitro Toxicity Testing Key Players in Central & South America
- 11.3 Central & South America In-vitro Toxicity Testing Market Size by Type
- 11.4 Central & South America In-vitro Toxicity Testing Market Size by Application
12 International Players Profiles
- 12.1 Abbott Laboratories
- 12.1.1 Abbott Laboratories Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 In-vitro Toxicity Testing Introduction
- 12.1.4 Abbott Laboratories Revenue in In-vitro Toxicity Testing Business (2014-2019))
- 12.1.5 Abbott Laboratories Recent Development
- 12.2 Agilent Technologies Inc.
- 12.2.1 Agilent Technologies Inc. Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 In-vitro Toxicity Testing Introduction
- 12.2.4 Agilent Technologies Inc. Revenue in In-vitro Toxicity Testing Business (2014-2019)
- 12.2.5 Agilent Technologies Inc. Recent Development
- 12.3 Bio-Rad Laboratories Inc.
- 12.3.1 Bio-Rad Laboratories Inc. Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 In-vitro Toxicity Testing Introduction
- 12.3.4 Bio-Rad Laboratories Inc. Revenue in In-vitro Toxicity Testing Business (2014-2019)
- 12.3.5 Bio-Rad Laboratories Inc. Recent Development
- 12.4 CELTHER POLSKA Sp z o.o.
- 12.4.1 CELTHER POLSKA Sp z o.o. Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 In-vitro Toxicity Testing Introduction
- 12.4.4 CELTHER POLSKA Sp z o.o. Revenue in In-vitro Toxicity Testing Business (2014-2019)
- 12.4.5 CELTHER POLSKA Sp z o.o. Recent Development
- 12.5 Charles River Laboratories International Inc.
- 12.5.1 Charles River Laboratories International Inc. Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 In-vitro Toxicity Testing Introduction
- 12.5.4 Charles River Laboratories International Inc. Revenue in In-vitro Toxicity Testing Business (2014-2019)
- 12.5.5 Charles River Laboratories International Inc. Recent Development
- 12.6 Eurofins GSC Lux Sarl
- 12.6.1 Eurofins GSC Lux Sarl Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 In-vitro Toxicity Testing Introduction
- 12.6.4 Eurofins GSC Lux Sarl Revenue in In-vitro Toxicity Testing Business (2014-2019)
- 12.6.5 Eurofins GSC Lux Sarl Recent Development
- 12.7 Evotec AG
- 12.7.1 Evotec AG Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 In-vitro Toxicity Testing Introduction
- 12.7.4 Evotec AG Revenue in In-vitro Toxicity Testing Business (2014-2019)
- 12.7.5 Evotec AG Recent Development
- 12.8 General Electric Co.
- 12.8.1 General Electric Co. Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 In-vitro Toxicity Testing Introduction
- 12.8.4 General Electric Co. Revenue in In-vitro Toxicity Testing Business (2014-2019)
- 12.8.5 General Electric Co. Recent Development
- 12.9 Merck KGaA
- 12.9.1 Merck KGaA Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 In-vitro Toxicity Testing Introduction
- 12.9.4 Merck KGaA Revenue in In-vitro Toxicity Testing Business (2014-2019)
- 12.9.5 Merck KGaA Recent Development
- 12.10 Thermo Fisher Scientific Inc.
- 12.10.1 Thermo Fisher Scientific Inc. Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 In-vitro Toxicity Testing Introduction
- 12.10.4 Thermo Fisher Scientific Inc. Revenue in In-vitro Toxicity Testing Business (2014-2019)
- 12.10.5 Thermo Fisher Scientific Inc. Recent Development
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Product (2019-2025)
- 13.2 Market Size Forecast by Application (2019-2025)
- 13.3 Market Size Forecast by Regions
- 13.4 North America
- 13.5 Europe
- 13.6 China
- 13.7 Japan
- 13.8 Southeast Asia
- 13.9 India
- 13.10 Central & South America
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 15.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
This report focuses on the global In-vitro Toxicity Testing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the In-vitro Toxicity Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Abbott Laboratories
Agilent Technologies Inc.
Bio-Rad Laboratories Inc.
CELTHER POLSKA Sp z o.o.
Charles River Laboratories International Inc.
Eurofins GSC Lux Sarl
Evotec AG
General Electric Co.
Merck KGaA
Thermo Fisher Scientific Inc.
Market segment by Type, the product can be split into
Static Well Plate System
Multi-compartmental Perfused Systems
Market segment by Application, split into
Pharmaceutical and Biotechnology Companies
Academic and Research Institutions
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global In-vitro Toxicity Testing status, future forecast, growth opportunity, key market and key players.
To present the In-vitro Toxicity Testing development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of In-vitro Toxicity Testing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.